The high purity of our highly potent active pharmaceutical ingredients guarantees our customers effective processes and consistently top quality for their products. Continuous enhancement of our knowledge enables them to maintain compliance with changing regulations and ensures a long-term drug supply.
Cancer cases are globally on the rise, causing an increasing demand for their treatment. Highly Potent Active Pharmaceutical Ingredients (HPAPIs) are the key compounds for chemotherapies, combination therapies in particular. Business Line Pharmaceutical Ingredients at Heraeus Precious Metals specializes in the production of generic HPAPIs as well as the exclusive synthesis of cytotoxic compounds from the research stage to registration to market launch.
Heraeus recently made a significant multi-million Euro investment building up its manufacturing capacity for platinum-based pharmaceutical ingredients to fight cancer. This is the company’s response to the global increase in demand for cancer drugs while consolidating its position as the global market leader for platinum-based active ingredients.